Table 1. Karyotypic analysis.
| sample | passage | days in culture (no. of CPD) | no. of mitoses (no. of slides) | karyotype | abnormalities |
|---|---|---|---|---|---|
| +C = with additional C-group chromosome (medium-sized, submetacentric human chromosomes); +mar = with marker chromosome (structurally abnormal chromosome in which no part can be identified) | |||||
| donor 4 | 5 | 25d (22.7) | 20 (15) | 46,XX | 1 x 47,XX,+C 1x 47,XX,+mar |
| 10 | 46d (34.8) | 16 (7) | 46,XX | - | |
| donor 8 | 5 | 21d (18.8) | 11 (4) | 46,XX | 1x 47,XX,+19 |
| 10 | 40d (32.8) | 22 (10) | 46,XX | - | |
| donor 10 | 3 | 14d (14.2) | 11 (4) | 46,XY | - |
| 10 | 44d (30.0) | 22 (10) | 46,XY | - | |
| donor 11 | 5 | 25d (22.9) | 14 (6) | 46,XX | - |
| 10 | 46d (36.2) | 14 (6) | 46,XX | - | |
| donor 12 | 8 | 36d (28.6) | 15 (6) | 46,XY | - |
| 32 | 185d (85.9) | 22 (10) | 46,XY | - | |